ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 236 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $369,477 | +122.6% | 15,427 | +30.8% | 0.01% | +66.7% |
| Q2 2022 | $166,000 | -0.6% | 11,793 | +17.5% | 0.00% | +200.0% |
| Q3 2021 | $167,000 | -32.4% | 10,036 | +67.4% | 0.00% | -80.0% |
| Q3 2020 | $247,000 | -86.3% | 5,996 | -83.8% | 0.01% | -91.5% |
| Q2 2020 | $1,799,000 | +3.6% | 37,117 | -8.6% | 0.06% | +84.4% |
| Q4 2019 | $1,737,000 | +239.9% | 40,605 | +186.0% | 0.03% | +128.6% |
| Q3 2019 | $511,000 | -76.5% | 14,200 | -82.5% | 0.01% | -77.0% |
| Q2 2019 | $2,176,000 | +1235.0% | 81,374 | +660.9% | 0.06% | +510.0% |
| Q2 2018 | $163,000 | -53.0% | 10,695 | +16.0% | 0.01% | -64.3% |
| Q3 2017 | $347,000 | -48.6% | 9,217 | -53.1% | 0.03% | -55.6% |
| Q1 2017 | $675,000 | – | 19,639 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |